Zephyr AI是一家专注于精准医疗领域的AI算法初创公司，近日宣布完成了1.1亿美元的A轮融资。公司致力于开发快速且可解释的人工智能解决方案，以推动医疗行业的精准医疗发展。本轮融资由Revolution Growth领投，参与的投资方还包括礼来公司、Jeff Skoll和EPIQ Capital Group。Zephyr AI的AI技术旨在提高医疗诊断的准确性和效率，为患者提供个性化的治疗方案。此次融资将用于进一步研发和扩大公司的业务范围，加快其产品在市场上的推广和应用。
Title: Zephyr AI Secures $110 Million in Series A Funding
Keywords: Precision Medicine, AI Algorithms, Startup
News content:
Zephyr AI, a startup specializing in AI algorithms for precision medicine, has announced the completion of a $110 million Series A funding round. The company focuses on developing fast and interpretable artificial intelligence solutions to advance the field of precision medicine. Revolution Growth led the funding round, with participation from Lilly, Jeff Skoll, and EPIQ Capital Group. Zephyr AI’s technology aims to enhance the accuracy and efficiency of medical diagnoses, offering personalized treatment plans for patients. The funding will be used to further research and development and expand the company’s operations, accelerating the adoption and application of its products in the market.
【来源】https://www.businesswire.com/news/home/20240312475536/en/Zephyr-AI-Raises-111-Million-in-Series-A-Financing
Views: 1